Infectious enteritis after intestinal transplantation: Incidence, timing, and outcome

Transplantation

Volumn 79, Issue 6, 2005, Pages 702-709

  Ziring, David ^a   Tran, Robert ^a   Edelstein, Susan ^a   McDiarmid, Sue V ^a   Gajjar, Nupoor ^a   Cortina, Galen ^a   Vargas, Jorge ^a   Renz, John F ^a   Cherry, James D ^a   Krogstad, Paul ^a   Miller, Marjorie ^a   Busuttil, Ronald W ^a   Farmer, Douglas G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Cryptosporidium; Cytomegalovirus; Epstein Barr virus; Infectious enteritis; Intestinal transplantation

Indexed keywords

ACICLOVIR; AZITHROMYCIN; BASILIXIMAB; CORTICOSTEROID; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PAROMOMYCIN; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; VANCOMYCIN;

ADENOVIRUS; ADULT; ANTIMICROBIAL THERAPY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONSERVATIVE TREATMENT; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DEMOGRAPHY; DIARRHEA; ENTERITIS; EPSTEIN BARR VIRUS; FEMALE; GIARDIA LAMBLIA; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION; INFECTIOUS ENTERITIS; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; LIVER GRAFT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTOZOON; RETROSPECTIVE STUDY; REVIEW; ROTAVIRUS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ENTERITIS; FOLLOW-UP STUDIES; HUMANS; INTESTINES; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 20144389516     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000154911.15693.80     Document Type: Review

References (40)

1. Grant D. Intestinal transplantation: 1997 Report of The International Registry. Transplantation 1999; 67: 1061-1064.
2. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001; 234: 404-416.
3. Nishida S, Levi D, Kato T, et al. Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg 2002; 6: 233-239.
4. Langnas A, Chinnakotla S, Sudan D, et al. Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. Transplant Proc 2002; 34: 958-960.
5. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcomes after intestinal transplantation: a single-center experience over a decade. Transplant Proc 2002; 34: 896-897.
6. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2. Arch Surg 2001; 136: 1027-1031.
7. Fishbein TM, Florman S, Gondolesi G, et al. Intestinal transplantation before and after the introduction of sirolimus. Transplantation 2002; 73: 1538-1542.
8. Farmer DG. Clinical immunosuppression for intestinal transplantation. Curr Opin Organ Transplant 2004; 9: 214-219.
9. Gerber DA, Green M, Jaffe R, et al. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000; 4: 50-55.
10. Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76(1): 183-189.
11. Delis SG, Tector J, Kato T, et al. Diagnosis and treatment of Cryptosporidium infection in intestinal transplant recipients. Transplant Proc 2002; 34: 951-952.
12. McLaughlin GE, Delis S, Kashimawo L, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant 2003; 3: 224-228.
13. Kaufman SS, Chatterjee NK, Fuschino ME, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 2003; 3: 764-768.
14. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.
15. Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2002; 2: 539-549.
16. Winston DJ, Wirin D, Shaked A, et al. Randomized comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995; 346: 69-74.
17. Farmer DG, McDiarmid SV, Winston D, et al. Effectiveness of aggressive prophylactic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation. Transplant Proc 2002; 34: 948-949.
18. Kaufman SS, Magid MS, Tschernia A, et al. Discrimination between acute rejection and adenoviral enteritis in intestinal transplant recipients. Transplant Proc 2002; 34: 943-945.
19. Berho M, Torroella M, Viciana A, et al. Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant 1998; 2: 277-282.
20. Levy MF, Crippin JS, Abbasoglu O, et al. Adenovirus infection of the human intestinal allograft: a case report. Transplant Proc 1996; 28: 2786-2787.
21. McGrath D, Falagas ME, Freeman R, et al. Adenovirus infection in adult orthotopic liver transplant recipients: Incidence and clinical significance. J Infect Dis 1998; 177: 459-462.
22. Michaels MG, Green M, Wald ER, et al. Adenovirus infection in pediatric liver-transplant recipients. J Infect Dis 1992; 165: 170-174.
23. Organ Procurement and Transplantation Network data of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1988-March 2004. (2004, June 29). 2004. Rockville, MD, and Richmond, VA, HHS/HRSA/OSP/DOT and United Network for Organ Sharing.
24. Starzl TE, Demetris AJ. Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth 1998; 19: 441-455.
25. Xia WY, Kirkman RL. Immune function in transplanted small intestine. Total secretory IgA production and response against cholera toxin. Transplantation 1990; 49: 277-280.
26. Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2002; 2(9): 539.
27. Athmanathan S, Bandlapally S, Rao GN. Comparison of the sensitivity of a 24 h-shell vial assay, and conventional tube culture, in the isolation of Herpes simplex virus-1 from corneal scrapings. BMC Clin Pathol 2002; 2: 1.
28. Rabenau H, Knoll B, Allwinn R, et al. Improvement of the specificity of enzyme immunoassays for the detection of rotavirus and adenovirus in fecal specimens. Intervirology 1998; 41: 55-62.
29. Parizhskaya M, Walpusk J, Mazariegos G, et al. Enteric adenovirus infection in pediatric small bowel transplant recipients. Pediatr Dev Pathol 2001; 4: 122-128.
30. Kapelushnik J, Or R, Delukina M, et al. Intravenous ribavirin therapy for adenovirus gastroenteritis after bone-marrow transplantation. J Pediatr Gastroenterol Nutr 1995; 21: 110-112.
31. Arav-Boger R, Echavarria M, Forman M, et al. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 2000; 19: 1097-1100.
32. Shetty AK, Gans HA, So S, et al. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000; 29: 69-73.
33. Carter BA, Karpen SJ, Quiros RE, et al. Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Hepatology 2002; 36: 662A.
34. Ribaud P, Scieux C, Freymuth F, et al. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999; 28: 690-691.
35. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621-626.
36. Green M, Bueno J, Rowe D, et al. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000; 70: 593-596.
37. Smith NH, Cron S, Valdez LM, et al. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis 1998; 178: 900-903.
38. Hicks P, Zwiener RJ, Squires J, et al. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr 1996; 129: 297-300.
39. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002; 360: 1375-1380.
40. Chen XM, Keithly JS, Paya CV, et al. Current concepts: cryptosporidiosis. N Engl J Med 2002; 346: 1723-1731.